Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval

Go back to Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 227.53 +2.17 (0.96%)
Previous Close $225.36    52 Week High $333.65 
Open $226.94    52 Week Low $223.02 
Day High $229.19    P/E 29.13 
Day Low $222.36    EPS $7.81 
Volume 1,494,461